Tropical Disease News and Research RSS Feed - Tropical Disease News and Research

Tropical diseases encompass all diseases that occur solely, or principally, in the tropics. In practice, the term is often taken to refer to infectious diseases that thrive in hot, humid conditions, such as malaria, leishmaniasis, schistosomiasis, onchocerciasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and dengue.
Segregating household sleeping arrangements can help prevent malaria spread

Segregating household sleeping arrangements can help prevent malaria spread

Better malaria control might come from segregating household sleeping arrangements, according to a new study co-authored by a University of Guelph professor. [More]
Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

​Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually-changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection. [More]
Mobilized medical care is necessary to better serve Haitian population after earthquake

Mobilized medical care is necessary to better serve Haitian population after earthquake

Three years after an earthquake killed more than 200,000 people and left an estimated 1.5 million people homeless in Haiti, a Henry Ford Hospital study found that more mobilized medical care is necessary to bridge cultural and health care barriers and better serve the Haitian population. [More]
Genetically modified bacterial treatment approach reduces or eliminates sleeping sickness

Genetically modified bacterial treatment approach reduces or eliminates sleeping sickness

A tag team of two bacteria, one of them genetically modified, has a good chance to reduce or even eliminate the deadly disease African trypanosomiasis, or sleeping sickness, researchers at Oregon State University conclude in a recent mathematical modeling study. [More]
PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies. [More]
Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

Low-cost intervention reduces transmission of lymphatic filariasis to undetectable levels

An international team of scientists have demonstrated that a simple, low-cost intervention holds the potential to eradicate a debilitating tropical disease that threatens nearly 1.4 billion people in more than six dozen countries. [More]
DNDi and Institut Pasteur Korea collaborates to spur fight against neglected diseases

DNDi and Institut Pasteur Korea collaborates to spur fight against neglected diseases

A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established. [More]
New research may influence development of anti-viral therapies to fight against Dengue

New research may influence development of anti-viral therapies to fight against Dengue

New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus. [More]
Men and women in Uganda face different challenges in accessing treatment for NTDs

Men and women in Uganda face different challenges in accessing treatment for NTDs

Males and females face different challenges in accessing treatment for neglected tropical diseases, according to a new study from researchers at the University of Toronto Dalla Lana School of Public Health, Uganda Ministry of Health and Imperial College London. [More]
Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis

Liverpool School of Tropical Medicine receives US$ 10 million to continue research against human filariasis

Liverpool School of Tropical Medicine (LSTM) has received US$ 10 million from the Bill & Melinda Gates Foundation to continue their breakthrough drug discovery and development research against human filariasis - parasitic worm infections which cause river blindness and elephantiasis, some of the world’s most debilitating diseases affecting up to 150 million people in 83 countries throughout the tropics. [More]
NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides, Inc. announced today that it has filed an Orphan Drug application with the Office of Orphan Product Development of the US FDA for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever. [More]
Queen's University Belfast scientists awarded research grants to tackle tropical diseases

Queen's University Belfast scientists awarded research grants to tackle tropical diseases

Queen's University Belfast has been announced as a Grand Challenges Explorations winner, an initiative founded by the Bill & Melinda Gates Foundation. Scientists at the University's Institute for Global Food Security have been awarded grants to pursue two Innovative global health and development research projects aimed at tackling tropical diseases. [More]
New NTD Special Envoys to focus on eliminating NTD primarily on LAC region

New NTD Special Envoys to focus on eliminating NTD primarily on LAC region

Today, the Global Network for Neglected Tropical Diseases, a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arz- Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization Director Dr. Mirta Roses Periago as the organization's newest Neglected Tropical Disease Special Envoys. [More]

Research suggests number of dengue cases three times higher than current WHO estimate

"Around 390 million people are infected each year with dengue fever -- the world's fastest-spreading tropical disease -- more than triple the current estimate by the World Health Organization, experts said on Sunday," Reuters reports. [More]

VOA News reports on pilot program against lymphatic filariasis in Nigeria

VOA News reports on "a new public health strategy, tested in Nigeria," which is "raising hopes" that the tropical disease known as lymphatic filariasis, or elephantiasis, can be eliminated. [More]
A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. [More]

NTDs have 'devastating consequences' for 1 out of 6 people worldwide

"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece. [More]
Texas Tech Professor receives NIH grant to research on leishmaniasis

Texas Tech Professor receives NIH grant to research on leishmaniasis

A Texas Tech University biology professor received a five-year, $1.6 million grant from the National Institutes of Health to study the biochemistry of a microscopic parasite responsible for the tropical disease leishmaniasis in the hope of finding a cure. [More]
Cell phone microscope can detect intestinal worm infections in children

Cell phone microscope can detect intestinal worm infections in children

Scientists working in rural Tanzania have used a simple US$8 glass lens, a strip of double-sided tape, and a cheap flashlight to convert an Apple iPhone into a field microscope that can successfully detect intestinal worm infections in children, according to a study published online today by the American Journal of Tropical Medicine and Hygiene. [More]
Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham enters into partnership to test furin for treatment of dengue fever

Sanford-Burnham Medical Research Institute and 60- Pharmaceuticals, LLC, have entered into a partnership to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics. [More]